Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengping Jiang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Cancer Medicine|October 13, 2021
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based studyShengnan Bao, Mengping Jiang, Xi Wang, et al.
British Journal of Cancer|May 18, 2024
HLA-A<sup>+</sup> tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinomaDandan Zhang, Dongxian Jiang, Liping Jiang, et al.
NPJ Precision Oncology|March 23, 2024
Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy responseZiqiang Chen, Xiaobing Wang, Zelin Jin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Cancer Medicine|October 13, 2021
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based studyShengnan Bao, Mengping Jiang, Xi Wang, et al.
British Journal of Cancer|May 18, 2024
HLA-A<sup>+</sup> tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinomaDandan Zhang, Dongxian Jiang, Liping Jiang, et al.
NPJ Precision Oncology|March 23, 2024
Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy responseZiqiang Chen, Xiaobing Wang, Zelin Jin, et al.
Pageof 2